Patent details

Basic Information

Publication number:

EP3085773

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161647466

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USES OF IL-1 ALPHA ANTIBODIES

French Title of Invention:

UTILISATION D'ANTICORPS IL-1 ALPHA

German Title of Invention:

VERWENDUNG VOM IL-1-ALPHA-ANTIKÖRPERN

SPC Number:

Dates

Filing date:

01/06/2009

Grant date:

18/03/2020

EP Publication Date:

26/10/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/03/2020

EP B1 Publication Date:

18/03/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

01/06/2020

Expiration date:

01/06/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/03/2020

 

 

Name:

XBiotech, Inc

Address:

1055 West Hastings Street, Suite 300, Vancouver, British Columbia V6E 2E9, Canada (CA)

Inventor

Name:

SIMARD, John

Address:

United States (US)

Priority

1

Priority Number:

57586 P

Priority Date:

30/05/2008

Priority Country:

United States (US)

2

Priority Number:

121391 P

Priority Date:

10/12/2008

Priority Country:

United States (US)

3

Priority Number:

178350 P

Priority Date:

14/05/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; C07K 14/545; C07K 16/00; C07K 16/24; C12N 5/16; G01N 33/68;

Publication

European Patent Bulletin

Issue number:

202012

Publication date:

18/03/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages